Cargando…
Recent Advances in the Discovery of Haem-Targeting Drugs for Malaria and Schistosomiasis
Haem is believed to be the target of some of the historically most important antimalarial drugs, most notably chloroquine. This target is almost ideal as haem is host-derived and the process targeted, haemozoin formation, is a physico-chemical process with no equivalent in the host. The result is th...
Autores principales: | de Villiers, Katherine A., Egan, Timothy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254801/ https://www.ncbi.nlm.nih.gov/pubmed/19701131 http://dx.doi.org/10.3390/molecules14082868 |
Ejemplares similares
-
A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
por: Siddiqui, Arif Jamal, et al.
Publicado: (2023) -
Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020) -
Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury
por: de Azevedo-Quintanilha, Isaclaudia G., et al.
Publicado: (2020) -
Is haem the real target of COVID-19?
por: Rapozzi, Valentina, et al.
Publicado: (2021) -
Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)